NEW YORK, Feb 3 (Reuters) - Schering-Plough Corp on Tuesday reported higher-than-expected quarterly earnings, helped by cost cutting, but sales of its two cholesterol drugs fell sharply amid continuing concerns about their effectiveness.
NEW YORK, Feb 3 (Reuters) - Schering-Plough Corp on Tuesday reported higher-than-expected quarterly earnings, helped by cost cutting, but sales of its two cholesterol drugs fell sharply amid continuing concerns about their effectiveness.
